Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History VTRS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics VTRS

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

283.88 %
Forward Annual Dividend Yield 5.41 %
Consecutive Years 0
Forward Annual Dividend 0.48 USD
Consistent Years 4
Dividend CAGR 3Y 13.30 %
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM 115.10 %
Dividend CAGR 10Y
Ex Dividend Date 23.05.2025

Viatris Inc

VTRS
Current price
8.88 USD -0.34 USD (-3.74%)
Last closed 9.27 USD
ISIN US92556V1061
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 10 880 014 336 USD
Yield for 12 month -23.91 %
1Y
3Y
5Y
10Y
15Y
VTRS
21.11.2021 - 28.11.2021

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. The company sells its products under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. It has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania. Address: Robert J. Coury Global Center, Canonsburg, PA, United States, 15317

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

11.39 USD

P/E Ratio

Dividend Yield

5.41 %

Financials VTRS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures VTRS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+14 739 300 000 USD

Last Year

+15 426 900 000 USD

Current Quarter

+3 254 300 000 USD

Last Quarter

+3 528 100 000 USD

Current Year

+5 623 600 000 USD

Last Year

+6 438 600 000 USD

Current Quarter

+1 161 200 000 USD

Last Quarter

+1 215 000 000 USD
EBITDA 4 216 499 968 USD
Operating Margin TTM 5.67 %
Price to Earnings
Return On Assets TTM 2.23 %
PEG Ratio 0.14
Return On Equity TTM -21.25 %
Wall Street Target Price 11.39 USD
Revenue TTM 14 330 200 064 USD
Book Value 13.20 USD
Revenue Per Share TTM
Dividend Share 0.48 USD
Quarterly Revenue Growth YOY -11.20 %
Dividend Yield 5.41 %
Gross Profit TTM 5 830 700 032 USD
Earnings per share -3.18 USD
Diluted Eps TTM -3.18 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -70.60 %
Profit Margin -26.45 %

Stock Valuation VTRS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 3.98
Enterprise Value Revenue 2.00
Price Sales TTM 0.76
Enterprise Value EBITDA 11.16
Price Book MRQ 0.67

Technical Indicators VTRS

For 52 Weeks

6.75 USD 13.19 USD
50 Day MA 8.88 USD
Shares Short Prior Month 43 003 872
200 Day MA 10.37 USD
Short Ratio 2.67
Shares Short 39 845 424
Short Percent 4.18 %